1. Home
  2. Labeler Index
  3. Proficient Rx Lp
  4. 71205-688
  5. Product Images: Tamsulosin Hydrochloride

Product Images Tamsulosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 71205-688 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

This is a figure and chart that shows the mean change from baseline in Total AUA Symptom Score for three different treatments over the course of 13 weeks. The treatments include O=0O—0-08mg, LNt 0.4mg, and placebo. The chart displays the duration of treatment in weeks and the number of participants for each treatment group.*

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

A graph showing the mean increase in peak urine flow rate (in L/Sec) in Study 1. The graph has three treatment groups: 0.4mg, 0.8mg, and placebo, represented by different symbols. The x-axis shows the duration of treatment (in weeks) and the y-axis shows the mean change in urine flow rate (in mL/sec). There are 5 data points on the graph, each representing a different time point during the study.*

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

This text explains the results of a study regarding the mean increase in peak urine flow rate. The study is identified as Study 2 and the data is presented in Figure 3B. The graph shows the duration of treatment in weeks on the x-axis and the mean increase in peak urine flow rate in mL/sec on the y-axis. There is also a legend describing the treatment group. However, there is no clear description of what the study was evaluating or what condition the treatment was for.*

71205-688-14 - tamsulosin fig6

71205-688-14 - tamsulosin fig6

This is a description of Tamsulosin HCI 0.4mg capsules, containing 14 capsules per package. The NDC number for this product is 71205-688-14, and it is distributed by Rising Health, LLC. The capsules are olive green and orange and imprinted with "53" and "on." Each capsule contains Tamsulosin hydrochloride USP 0.4mg. This drug is available only with a prescription and should be kept out of reach of children. The capsules should be stored at a temperature of 20°-25°C (68°-77°F).*

Chemical Structure - tamsulosin str

Chemical Structure - tamsulosin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.